Bilateral Uterine Artery Ligation in PPC Technique for Management of PAS

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

130 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-04-01

Study Completion Date

2022-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Aim of the study

Primary outcomes:

1. The effect of bilateral uterine artery ligation in reducing intraoperative bleeding in women underwent PPC as a conservative surgical technique.
2. Decrease surgical time.

Secondary outcomes:

1. Associated maternal morbidity and mortality.
2. Amount of blood transfusion
3. Difference in hematocrit value before and after delivery

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effectivness of Conservative Techniques in Management of PAS

NCT05104177

Placenta Accreta

UNKNOWN

Evaluation of Planned Conservative Surgical Management of Placenta Accreta Spectrum in Women's Health Center, Assiut University Hospital

NCT06712576

Placenta Accreta

NOT_YET_RECRUITING

Evaluation of Different Surgical Approaches Used for Conservative Management of Placenta Accreta Spectrum in Sohag University Hospital

NCT05510076

Placenta Accreta Spectrum

UNKNOWN

Surgical Technique To Control Postpartum Hemorrhage

NCT03241849

Post Partum Hemorrhage

COMPLETED NA

Placenta Accreta; Total Lower Uterine Segmentectomy With Cervico-corporeal Anastomosis

NCT05419804

Placenta Accreta

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Introduction Placenta accreta spectrum (PAS) is a term that comprises abnormal placental invasion disorders of the uterine wall. According to the depth of invasion, it ranges from placental invasion in contact with myometrium (placenta accreta), into myometrium (placenta increta), or beyond myometrium (placenta percreta) (Tan, Tay et al. 2007, Cal, Ayres-de-Campos et al. 2018). PAS is an obstetric emergency that may be complicated by emergency hysterectomy, intraoperative surgical complications, massive transfusion, hemorrhagic shock, and even maternal death if not managed efficiently (Ye 2017). Previous cesarean deliveries, placenta previa and advanced maternal age are recognized strong risk factors of PAS, all of which, have become more prevalent among contemporary population (Silver, Landon et al. 2006, Zeng, Yang et al. 2018). Therefore, PAS is no longer a rare disorder in modern practice; the incidence of PAS has increased from approximately 1 in 30,000 deliveries before 1950 to 3 in 1000 deliveries in the current decade (Timor-Tritsch, Monteagudo et al. 2012).

Currently, cesarean hysterectomy is the standard management of PAS (Matsubara, Kuwata et al. 2013). Despite surgical risks, loss of uterine function, and psychological sequences, cesarean hysterectomy permits elective intervention under controlled settings to minimize blood loss (2002). Although several uterus-conserving interventions have been proposed in management of PAS, their contribution to evidence-based practice is limited (Jauniaux, Alfirevic et al. 2018), and cesarean hysterectomy is endorsed as the standard intervention (gynaecology, Gynaecology et al. 2002). Cesarean hysterectomy, without attempting to remove the placenta, may reduce risk of significant bleeding and associated morbidity (Eller, Porter et al. 2009). Leaving the placenta in situ is endorsed as an alternative in patients who refuse hysterectomy being the least invasive uterus-conserving intervention (Jauniaux, Alfirevic et al. 2018, Sentilhes, Kayem et al. 2018).

Nevertheless, the need for evidence-based conservative approaches for PAS cannot be underestimated particularly among women who are highly motivated to preserve their fertility. Despite limited evidence, an international survey indicates that 39% of obstetricians consider conservative management as the primary management. Notably, conservative management was inconsistent among respondents (Cal, Ayres-de-Campos et al. 2018).

Placental pouch closure looks to be an attractive and effective surgical procedure for conservative management of placenta accreta (Zahran, Elsonbaty et al. 2020). In their series of 60 Placenta accreta cases reported that by using this technique,59 out of the 60 enrolled cases, the uterus was successfully conserved and there were no cases of maternal mortality or severe morbidities related to the procedure.

Major blood supply of the uterus comes from the uterine artery, so bilateral uterine artery ligation (UAL) before delivering of the placenta greatly decreasing the blood loss(Lin, Lin et al. 2019). Simultaneously, the ovarian blood flow has not been affected and consequently no changes in ovarian reserve markers occurred, so it is considered one of preserving fertility surgical technique (Verit, Çetin et al. 2019).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Placenta Accreta

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

modified technique

women were underwent modified technique (PPC+ bilateral uterine artery ligation)

Group Type EXPERIMENTAL

bilateral uterine artery ligation

Intervention Type PROCEDURE

* Spinal anaethesia with intrathecal morphia
* Transverse skin incision
* Adequate dissection of the bladder.
* Incision of the uterus above placental edge.
* Delivery of the fetus.
* Delayed cord clamping (60 seconds) if the baby appears well.
* Exteriorization of the uterus.
* Start Oxytocin infusion and uterine massage to ensure good uterine contractions immediately after delivery of the fetus. No trials of placental delivery will be made at this point.
* At this point, a gentile trial to deliver the placenta is performed
* A catheter is placed in the cervix from above to secure the cervical opening
* Compression is applied to the site of bleeding from placenta site
* Placental pouch is marked by multiple allies and is closed down to the multiple-8 suture.
* Blood loss is measured using the suction device and coated socked towels. In modified PPC, Bilateral uterine artery ligation will be done after exteriorization of the uterus in order to minimize the blood loss.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

bilateral uterine artery ligation

* Spinal anaethesia with intrathecal morphia
* Transverse skin incision
* Adequate dissection of the bladder.
* Incision of the uterus above placental edge.
* Delivery of the fetus.
* Delayed cord clamping (60 seconds) if the baby appears well.
* Exteriorization of the uterus.
* Start Oxytocin infusion and uterine massage to ensure good uterine contractions immediately after delivery of the fetus. No trials of placental delivery will be made at this point.
* At this point, a gentile trial to deliver the placenta is performed
* A catheter is placed in the cervix from above to secure the cervical opening
* Compression is applied to the site of bleeding from placenta site
* Placental pouch is marked by multiple allies and is closed down to the multiple-8 suture.
* Blood loss is measured using the suction device and coated socked towels. In modified PPC, Bilateral uterine artery ligation will be done after exteriorization of the uterus in order to minimize the blood loss.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* • Previous operations

* Gestational age (28 weeks)
* Prenatally suspected PAS based on sonographic and/or MRI findings and/or intrapartum diagnosis of PAS.
* Authorization to participate in the study

Exclusion Criteria

* • Coagulopathies

* Chronic renal or hepatic impairment (baseline first trimester labs are beyond normal range for pregnancy)
* Delivery in an outside hospital (patients referred for ongoing massive bleeding due to PAS)
* Patients coming in emergency condition with bleeding or in labour.

Minimum Eligible Age

16 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No